Emmanuel J Favaloro/LinkedIn
Nov 12, 2025, 10:55
Thrombophilia Testing․ What’s New and What Still Matters?
Emmanuel J Favaloro, Lead Scientist at Sydney Centres for Thrombosis and Haemostasis, Westmead Hospital, posted on LinkedIn.
” Latest publication from the Sydney Centres for Thrombosis and Haemostasis based at Westmead Hospital. Editorial on thrombophilia testing; free to download from here
but only for the first 50 visits. Thereafter, standard access applies; send me an email if you want a copy but can’t access through your institution.”
Stay updated with Hemostasis Today.
-
Jul 13, 2026, 11:25Luisa Müller: Advancing Anticoagulation Strategies for VITT at ISTH 2026
-
Jul 13, 2026, 10:49Joshua Zeidner: Advancing Menin Inhibitor Therapy in MD Education AML-ALL US Focus 2026
-
Jul 13, 2026, 10:25Flora Peyvandi: A Practical Approach to ALT Elevation After Gene Therapy at ISTH 2026
-
Jul 13, 2026, 10:02Jessica Garcia: Where Science and Community Come Together at ISTH 2026
-
Jul 13, 2026, 09:46Fabrice Cognasse: Is There Such a Thing as the Perfect Platelet Product?
-
Jul 13, 2026, 09:42Cancer-Associated Arterial Thromboembolism: Redefining the Thrombotic Burden in Oncology
-
Jul 13, 2026, 05:59Connecting and Collaborating at ISTH 2026 – NNHF
-
Jul 13, 2026, 05:58Lara Monica: Back at ISTH – Looking Forward to Science and Reconnections!
-
Jul 13, 2026, 05:57Barbara Adams Krolak: Exciting Updates From the ISTH 2026 Regulatory Session